Real Housewives of Beverly Hills alum Teddi Mellencamp shared her heartbreaking reaction after a fan weighed in on her ...
Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...
The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...
In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...
A 40-gene expression profile test can improve risk stratification for patients with CSCC, according to researchers.
The supervisory board of the Company has reviewed the financial statements 2024 on April 2nd, 2025 and the Company's ...
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
A live webcast and replay of the fireside chat will be available on the Events & Presentations page in the Investor Relations section of Pyxis Oncology’s website, ir.pyxisoncology.com.
BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.
On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...
The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results